U.S. stocks were lower, with the Dow Jones index falling around 100 points on Thursday.
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) rose sharply during Thursday's session after the company reported better-than-expected first-quarter financial results.
Tilray Brands posted adjusted earnings of $0.00 per share, beating market expectations of a loss of $0.02 per share. The company's sales came in at $209.501 million versus estimates of $204.549 million.
Tilray Brands shares jumped 30% to $2.2397 on Thursday.
Here are some other big stocks recording gains in today’s session.
- Diginex Limited (NASDAQ:DGNX) surged 23% to $38.13 after jumping 28% on Wednesday.
- NOVONIX Limited (NASDAQ:NVX) gained 22.3% to $2.3650.
- Critical Metals Corp. (NASDAQ:CRML) rose 19.2% to $14.07.
- Serve Robotics Inc. (NASDAQ:SERV) gained 18.5% to $16.29. DoorDash (NASDAQ:DASH) and Serve Robotics announced a new multi-year strategic partnership to roll out autonomous robot deliveries across the U.S.
- POMDOCTOR LIMITED (NASDAQ:POM) gained 17.1% to $4.7206.
- Akero Therapeutics, Inc. (NASDAQ:AKRO) rose 16.6% to $54.23 after the company announced it will be acquired by Novo Nordisk for up to $5.2 billion.
- Byrna Technologies Inc. (NASDAQ:BYRN) gained 15.8% to $26.42 after the company reported better-than-expected quarterly EPS results.
- Ramaco Resources, Inc. (NASDAQ:METC) rose 11.3% to $46.19.
- UiPath Inc. (NYSE:PATH) gained 10.5% to $17.22. According to Fortune, UiPath is shifting from traditional Robotic Process Automation (RPA) to “agentic” automation, embedding AI agents for complex tasks and strengthening its platform through strategic collaborations, including a ChatGPT connector with OpenAI.
- Energy Fuels Inc. (NASDAQ:UUUU) rose 9.9% to $19.76.
- Albemarle Corporation (NYSE:ALB) jumped 7.9% to $98.94.
- ABIVAX Société Anonyme (NASDAQ:ABVX) gained 7.8% to $93.29.
- TeraWulf Inc. (NASDAQ:WULF) gained 7.6% to $13.25.
- Delta Air Lines, Inc. (NYSE:DAL) rose 6.1% to $60.60 after the company reported better-than-expected third-quarter financial results and raised FY25 EPS outlook.
Read This Next:
Photo via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.